Page last updated: 2024-10-24

bupivacaine and Guillain-Barre Syndrome

bupivacaine has been researched along with Guillain-Barre Syndrome in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Guillain-Barre Syndrome: An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory muscles and autonomic dysfunction may occur. (From Adams et al., Principles of Neurology, 6th ed, pp1312-1314)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wipfli, M1
Arnold, M1
Luginbühl, M1

Other Studies

1 other study available for bupivacaine and Guillain-Barre Syndrome

ArticleYear
Repeated spinal anesthesia in a tetraparetic patient with Guillain-Barré syndrome.
    Journal of clinical anesthesia, 2013, Volume: 25, Issue:5

    Topics: Aged; Anesthesia, Spinal; Anesthetics, Local; Bupivacaine; Fentanyl; Guillain-Barre Syndrome; Humans

2013